Xanodyne

edit

Xanodyne Pharmaceuticals, founded in 2001, is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management. The company markets a portfolio of revenue generating products consisting of prescription pharmaceuticals and a line of prenatal vitamins, and we are advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne’s focus areas.

Milestones

edit

• Received $38M in Series D funding. (6/23/09)
  Posted 6/23/09 at 10:21am

Videos

Screenshots

edit

Sources

1. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]